(Q42991272)

12 November 2017

Feasibility of individualized treatment for hepatitis C patients in the real world (English)

1 reference

12 November 2017

Tsung-Ming Chen

1

1 reference

12 November 2017

Pi-Teh Huang

2

1 reference

12 November 2017

Ching-Heng Lin

3

1 reference

12 November 2017

Ming-Hung Tsai

4

1 reference

12 November 2017

Lien-Fu Lin

5

1 reference

12 November 2017

Chung-Cheng Liu

6

1 reference

12 November 2017

Ka-Sic Ho

7

1 reference

12 November 2017

Jai-Nien Tung

8

1 reference

12 November 2017

25 September 2009

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

1 reference

12 November 2017

25

1 reference

12 November 2017

1

1 reference

12 November 2017

61-69

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05946.X

Crossref

reference URL

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05946.X

Crossref

reference URL

Reporting the recruitment process in clinical trials: who are these patients and how did they get there?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2009.05946.X

Crossref

reference URL

10.1111/J.1440-1746.2009.05946.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference